You may also like
Renal Safety of Hydroxyethyl starch 130/0.42 After Cardiac Surgery: A Retrospective Cohort Analysis
This study showed no association between HES and the postoperative occurrence of acute kidney injury and thus further closes the evidence gap on HES safety in cardiac surgery patients. Although this was a retrospective cohort study, the results indicated that HES might be safely administered to cardiac surgery patients with regard to renal outcomes, especially if it was administered early and dosed appropriately.
Transcatheter Aortic Valve Replacement: Current Developments, Ongoing Issues, Future Outlook
Careful patient selection, systematic risk stratification, optimal valve sizing, meticulous procedural techniques, and complications management are all important elements to achieve good outcomes. Future prospective studies will allow us to refine this therapy and optimize outcomes in this high-risk patient population.
MAQUET Takes Over U.S. Distribution of Jostra Product Line
Dear Customer: Effective April 5, 2004 NOVOSCI will cease to be the distributor of Jostraproducts in the United States and MAQUET Inc. […]
